Welcome to LookChem.com Sign In|Join Free

CAS

  • or

78286-57-4

Post Buying Request

78286-57-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

78286-57-4 Usage

Chemical compound

Yes

Physical state

White, crystalline solid

Solubility

Soluble in water

Uses

a. Intermediate in the synthesis of pharmaceuticals and agrochemicals
b. Bacteriostatic agent in antifungal and antibacterial formulations
c. Reagent in the production of dyes and pigments
d. Manufacturing of rubber products

Microorganism growth inhibition

Yes

Safety precautions

a. Harmful if ingested or inhaled
b. Can cause skin and eye irritation
c. Handle with care

Check Digit Verification of cas no

The CAS Registry Mumber 78286-57-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,2,8 and 6 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 78286-57:
(7*7)+(6*8)+(5*2)+(4*8)+(3*6)+(2*5)+(1*7)=174
174 % 10 = 4
So 78286-57-4 is a valid CAS Registry Number.

78286-57-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name N-cyano-N'-methyl-thiourea

1.2 Other means of identification

Product number -
Other names N-Cyan-N'-methyl-thioharnstoff

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:78286-57-4 SDS

78286-57-4Relevant articles and documents

Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement

Buchholz, Mirko,Hamann, Antje,Aust, Susanne,Brandt, Wolfgang,B?hme, Livia,Hoffmann, Torsten,Schilling, Stephan,Demuth, Hans-Ulrich,Heiser, Ulrich

experimental part, p. 7069 - 7080 (2010/05/02)

The inhibition of human glutaminyl cyclase (hQC) has come into focus as a new potential approach for the treatment of Alzheimer's disease. The hallmark of this principle is the prevention of the formation of Aβ 3,11(pE)-40,42, as these Aβ-speci

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 78286-57-4